Recombinant myelin oligodendrocyte glycoprotein quality modifies evolution of experimental autoimmune encephalitis in macaques

[1]  C. Power,et al.  Bacterial Peptidoglycan as a Driver of Chronic Brain Inflammation. , 2020, Trends in molecular medicine.

[2]  N. Tchitchek,et al.  Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases , 2019, Journal of Neuroinflammation.

[3]  H. Lassmann,et al.  Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination , 2017, Journal of Neuroinflammation.

[4]  S. Tiwari-Woodruff,et al.  Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair , 2017, Journal of Neuroscience Methods.

[5]  J. Armengaud,et al.  RNA-binding proteins are a major target of silica nanoparticles in cell extracts , 2016, Nanotoxicology.

[6]  R. Mellanby,et al.  LPS-matured CD11c+ bone marrow-derived dendritic cells can initiate autoimmune pathology with minimal injection site inflammation , 2016, Laboratory animals.

[7]  W. Zhai,et al.  Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis , 2016, Journal of Neuroimmune Pharmacology.

[8]  B. '. ’t Hart,et al.  The primate autoimmune encephalomyelitis model; a bridge between mouse and man , 2015, Annals of clinical and translational neurology.

[9]  A. Chaudhuri,et al.  EAE is not a useful model for demyelinating disease. , 2014, Multiple sclerosis and related disorders.

[10]  P. Popovich,et al.  Pattern recognition receptors and central nervous system repair , 2014, Experimental Neurology.

[11]  Haiyan Zhou,et al.  Differential IL‐10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction , 2014, European journal of immunology.

[12]  C. Janeway,et al.  Pillars article: approaching the asymptote? Evolution and revolution in immunology. Cold spring harb symp quant biol. 1989. 54: 1-13. , 2013, Journal of immunology.

[13]  B. '. ’t Hart,et al.  Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund’s Adjuvant in Three Non-human Primate Species , 2013, Journal of Neuroimmune Pharmacology.

[14]  C. Mallard.  Innate Immune Regulation by Toll-Like Receptors in the Brain , 2012, ISRN neurology.

[15]  C. Lucchinetti,et al.  Pathology of demyelinating diseases. , 2012, Annual review of pathology.

[16]  E. Meinl,et al.  Therapeutic Advances in Neurological Disorders Glycoproteins as Targets of Autoantibodies in Cns Inflammation: Mog and More Therapeutic Advances in Neurological Disorders Review , 2022 .

[17]  W. Banks,et al.  Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: Multiplex quantification with path analysis , 2011, Brain, Behavior, and Immunity.

[18]  J. Armengaud,et al.  Proteomic insights into the lifestyle of an environmentally relevant marine bacterium , 2011, The ISME Journal.

[19]  S. Nadler,et al.  Targeting lymphocyte co-stimulation: From bench to bedside , 2010, Autoimmunity.

[20]  B. '. ’t Hart,et al.  Induction of Progressive Demyelinating Autoimmune Encephalomyelitis in Common Marmoset Monkeys Using MOG34-56 Peptide in Incomplete Freund Adjuvant , 2010, Journal of neuropathology and experimental neurology.

[21]  N. Carbonetti,et al.  Pertussis Toxin Stimulates IL-17 Production in Response to Bordetella pertussis Infection in Mice , 2009, PloS one.

[22]  D. Fitzgerald,et al.  Role of the innate immune system in autoimmune inflammatory demyelination. , 2008, Current medicinal chemistry.

[23]  P. Cabot,et al.  A model of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice for the characterisation of intervention therapies , 2007, Journal of Neuroscience Methods.

[24]  D. Bourdette,et al.  Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis , 2007, Journal of Neuroimmunology.

[25]  H. Stolp,et al.  Breakdown of the blood–brain barrier to proteins in white matter of the developing brain following systemic inflammation , 2005, Cell and Tissue Research.

[26]  B. Lambrecht,et al.  Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease , 2005, The Journal of Immunology.

[27]  M. Mostarica‐Stojković,et al.  Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant , 2004, Clinical and experimental immunology.

[28]  R. Fujinami,et al.  Antibody Association with a Novel Model for Primary Progressive Multiple Sclerosis: Induction of Relapsing‐Remitting and Progressive Forms of EAE in H2S Mouse Strains , 2000, Brain pathology.

[29]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[30]  John T. Chang,et al.  CpG Oligonucleotides Are Potent Adjuvants for the Activation of Autoreactive Encephalitogenic T Cells In Vivo , 2000, The Journal of Immunology.

[31]  E. Shevach,et al.  Microbial products induce autoimmune disease by an IL-12-dependent pathway. , 1997, Journal of immunology.

[32]  M. Lukic,et al.  Dissection of adjuvant and suppressive effects of mycobacteria in experimental allergic encephalomyelitis production. , 1988, International archives of allergy and applied immunology.

[33]  J. Frelinger,et al.  Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes , 1982, The Journal of experimental medicine.

[34]  H. Sedlacek,et al.  Influence of various immunomodulators on the induction of experimental autoimmune encephalomyelitis in Lewis rats. , 1980, Immunobiology.

[35]  A. Waisman,et al.  Modeling a complex disease: Multiple sclerosis-Update 2020. , 2021, Advances in immunology.

[36]  C. Serguera,et al.  Experimental Models of Autoimmune Demyelinating Diseases in Nonhuman Primates , 2018, Veterinary pathology.

[37]  B. '. ’t Hart,et al.  Experimental Autoimmune Encephalomyelitis in Marmosets. , 2016, Methods in molecular biology.

[38]  J. Armengaud,et al.  Taking the shortcut for high-throughput shotgun proteomic analysis of bacteria. , 2014, Methods in molecular biology.

[39]  L. Trümper.  From bench to bedside , 2005, Medizinische Klinik.

[40]  Y. Mauss,et al.  The role of Mycobacterium tuberculosis in experimental allergic encephalomyelitis. , 1994, European neurology.

[41]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[42]  I. Mackay,et al.  Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen. , 1984, Cellular immunology.

[43]  S. Kusumoto,et al.  Minimum structural requirements for encephalitogen and for adjuvant in the induction of experimental allergic encephalomyelitis. , 1978, Cellular immunology.

[44]  L. Zimmerman,et al.  Pathology of the demyelinating diseases. , 1956, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.